HEG PAT Soars 43% YoY To ₹206 Cr, But Exceptional Losses Surge

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorAarav Shah|Published at:
HEG PAT Soars 43% YoY To ₹206 Cr, But Exceptional Losses Surge
Overview

HEG Limited reported a robust 43.26% year-on-year (YoY) surge in consolidated Profit After Tax (PAT) to ₹205.97 crore for Q3 FY26, driven by a 36.99% YoY increase in revenue to ₹655.33 crore. Standalone PAT also grew 43.67% YoY. However, consolidated results were significantly impacted by a sharp rise in exceptional item losses, increasing from ₹7.26 crore to ₹55.14 crore, leading to a decline in consolidated profit before tax. Standalone EPS for the quarter also saw a YoY decrease. The company also approved a ₹400 crore investment in subsidiary TACC Limited and a corporate guarantee for its credit facilities.

📉 The Financial Deep Dive

The Numbers:
HEG Limited announced strong year-on-year (YoY) growth in its Q3 FY26 results. Consolidated Profit After Tax (PAT) surged by 43.26% to ₹205.97 crore, up from ₹143.77 crore in Q3 FY25. Consolidated revenue from operations climbed 36.99% YoY to ₹655.33 crore. On a standalone basis, revenue saw an even stronger 37.44% YoY rise to ₹655.66 crore, with PAT jumping 43.67% YoY to ₹141.25 crore.

The Quality & Red Flags:
Despite the impressive top and bottom-line growth, quality of earnings remains a concern. Consolidated results were significantly weighed down by exceptional item losses, which escalated dramatically from ₹7.26 crore in Q3 FY25 to ₹55.14 crore in Q3 FY26 – an increase of over 650%. This surge in exceptional losses led to a decline in consolidated profit before tax and associates, masking the underlying operational strength. Furthermore, standalone Earnings Per Share (EPS) for the quarter witnessed a year-on-year decrease, a detail that warrants investor attention.

Strategic Moves & Associate Issues:
In terms of strategic corporate actions, HEG Limited's Board approved a significant ₹400 crore subscription to Optionally Convertible Debentures (OCDs) in its wholly-owned subsidiary, TACC Limited, aimed at bolstering its advanced carbon materials business. A Corporate Guarantee was also sanctioned in favour of State Bank of India for credit facilities to be availed by TACC. On the other hand, the company decided to wind down the Medical Transcription Business of Bhilwara Infotechnology Limited due to declining revenues, effective March 1, 2026. Associate companies faced project challenges, with one project reportedly on hold due to regulatory concerns and another having been surrendered, indicating potential execution risks in the broader group structure.

🚩 Risks & Outlook

The primary risks revolve around the escalating exceptional item losses, which impact the true profitability of the consolidated entity. The decline in standalone EPS and unresolved project issues within associate companies add to the cautious outlook. While the investment in TACC Limited signals a strategic pivot towards new-age materials, its success and financial integration will be crucial. Investors should monitor the management's commentary on cost control, the resolution of associate company issues, and the future impact of exceptional items in subsequent quarters.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.